SELLAS Life Sciences Group, Inc.
SLS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001390478
No open-market purchases or sales by SELLAS Life Sciences Group, Inc. insiders were filed in the last 90 days; 193 institutions reported holding it in 13F filings for Q2 2026, worth $1.08B in total; no superinvestor holds it.
Q1 2023 vs. Q4 2022
How the institutions holding SELLAS Life Sciences Group, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Q1 2023 | Change |
|---|---|---|---|
| Holders | 29 | 22 | −7 |
| Shares | 1.89M | 3.00M | +1.11M (+58.6%) |
| Value | $4.46M | $4.28M | −$171.3K (−3.8%) |
New holders (3)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Alyeska Investment Group, L.P. | 1,250,000 | $1.79M | 0.02% |
| Values First Advisors, Inc. | 15 | $21 | 0.00% |
| WealthPLAN Partners, LLC | 1 | $1 | 0.00% |
Sold out (10)
Institutions that held SELLAS Life Sciences Group, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Millennium Management LLC | 61,179 | $144.0K |
| XTX Topco Ltd | 55,403 | $130.8K |
| Virtu Financial LLC | 18,379 | $43.0K |
| Two Sigma Securities, LLC | 16,076 | $37.9K |
| Citadel Advisors LLC | 3,375 | $7.96K |
| Global Retirement Partners, LLC | 1,000 | $2.36K |
| Citigroup Inc | 100 | $236 |
| Bank of America Corp | 48 | $114 |
| Godsey & Gibb Associates | 4 | $9 |
| Cutler Group LP | 300 | $0 |